期刊
JOURNAL OF ALLOYS AND COMPOUNDS
卷 749, 期 -, 页码 939-947出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.jallcom.2018.03.355
关键词
Controllable synthesis; UCNPs@ MIL-PEG; Up-conversion luminescence; MRI; pH-responsive
资金
- Natural Science Foundation of Hubei Province [2017CFB530]
- Wuhan Morning Light Plan of Youth Science and Technology [2017050304010282]
- National Natural Science Foundation of China [51302071]
- Australian Research Council [CE140100036, DP0987407, DP110104299, LE0775684, LE0668517, LE0882357]
- National Health and Medical Research Council [APP1021759]
- University of Queensland [UQECR1720289]
Rare-earth doped up-conversion nanoparticles (UCNPs) with high uniformity and dispersibility were synthesized by a facile solvothermal method. The conditions of synthesis for NaYF4: Yb/Tm were explored, and the NaYF4: Yb/Tm particles with the optimal size (about 300 nm) were obtained. Blue emission was observed with the excitation 980 nm near infrared (NIR) laser, indicating that the UCNPs can be potentially used for up-conversion luminescence (UCL) imaging. On basis of the optimal UCNPs, further coated by poly (ethylene glycol) (PEG) functionalized metal-organic frameworks (MOFs), a multifunctional platform UCNPs@MIL-PEG for cancer diagnosis and treatment was established. The core-shell structure was confirmed by TEM images. Doxorubicin (DOX) was selected as drug model and the drug loading of UCNPs@MIL-PEG was found to be 60%. Cytotoxicity indicated that UCNPs@MIL-PEG were highly biocompatible. The DOX release in different pH value revealed an excellent pH-triggered drug release. In addition, the UCNPs@ MIL-PEG nanoparticles can be tracked by magnetic resonance imaging (MRI). A clear dose-dependent contrast enhancement in T-2-weighted MR images indicated the potential act as T-2 MRI contrast agents. The UCNPs@MIL-PEG nanoparticles are expected to be simultaneously used for UCL/MR dual-mode imaging and pH-responsive drug release. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据